Andere Sprachen Illumina, Inc.

Aktien

927079

US4523271090

ILMN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 23.04.2024			% 5 Tage	% 1. Jan.
124,5 ^USD	+3,50 %		+5,75 %	-10,61 %

23.04.	ILLUMINA, INC. : Bernstein klebt neutral	ZM
23.04.	ILLUMINA, INC. : Baird bleibt neutral	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Illumina : 2024 Assurance Statement	23.04.
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16.04.
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16.04.
Illumina's planned divestment of GRAIL approved by the European Commission	15.04.
The European Commission Approves Illumina's Plan to Divest Grail	15.04.
Illumina's planned divestment of GRAIL approved by the European Commission	12.04.
Illumina Secures European Commission's Approval for Grail Divestment	12.04.
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail	12.04.
EU approves Illumina's plan to divest cancer test maker Grail	12.04.
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	09.04.
Illumina Names Ankur Dhingra as Chief Financial Officer	09.04.
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor	09.04.
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer	09.04.
Illumina, Inc. Announces Chief Financial Officer Changes	09.04.
Illumina, Inc. Announces Executive Changes	09.04.
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024	04.04.
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting	28.03.
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday	21.03.
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger	21.03.
Boost for Illumina as court adviser rejects EU merger powers	21.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Illumina, Inc.

Aktien

927079

US4523271090

ILMN

Andere Sprachen

Filter